REDESCA HP
REDESCA HP
Approved
DIN Number
02509156
Drug Class
Human
Market Date
Apr 9, 2021
Company
HC
Shenzhen Techdow Pharmaceutical Co., Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02509156
AIG Number0131860002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB05 ENOXAPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Subcutaneous
AHFS Classification20:12.04.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
ENOXAPARIN SODIUMActive
Strength: 150 MG / ML
Monograph: ENOXAPARIN SODIUM